Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

17 Oct 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


AstraZeneca Pharma India Limited is a global biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The Company operates through two... (more)
No analyst recommendations are available for .


Beta: 0.50
Market Cap(Mil.): Rs23,732.50
Shares Outstanding(Mil.): 25.00
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 30.44 16.24
EPS (TTM): -- -- --
ROI: -- 14.17 10.90
ROE: -- 15.52 14.09

BRIEF-Astrazeneca Pharma India gets marketing approval for combination of therapies for type 2 diabetes‍​

* Gets marketing approval for Xigduo XR, combination of two anti-diabetic therapies for type 2 diabetes‍​ Source text: http://bit.ly/2yviJMD Further company coverage:

17 Oct 2017

BRIEF-Astrazeneca Pharma India seeks shareholders' nod for appointment of Gagan Singh Bedi as MD

* Seeks shareholders' nod for for appointment of Gagan Singh Bedi as a managing director Source text - http://bit.ly/2uYHFf1 Further company coverage:

21 Aug 2017

BRIEF-Astrazeneca Pharma India June-qtr profit falls

* Profit in June quarter last year was 126 million rupees as per IND-AS; total revenue was 1.42 billion rupees

08 Aug 2017

BRIEF-Astrazeneca Pharma India appoints Gagan Singh Bedi as MD of co

* Says Sanjay Murdeshwar has offered to resign as managing director of company

29 Jun 2017

BRIEF-Astrazeneca Pharma India gets import and market permission from DCGI for FDC of asthma drug

* Received import and market permission in form 45 from DCGI (Drug Controller General of India)for FDC of Budesonide 320 μg + Formoterol Fumarate Dihydrate 9 μg inhalation powder

15 Jun 2017

Sensex, Nifty hit record closing high

Indian shares closed at a record high on Tuesday, with the NSE Nifty crossing 9,500 points intraday for the first time ever, as expectations of good monsoon rains eased inflation fears and bolstered the economic growth outlook.

16 May 2017

Indian shares hit all-time high in record-setting spree

May 16 Indian shares continued their record-setting spree on Tuesday, hitting all-time highs for the third time in five sessions, as investors remained bullish about the prospects of a good monsoon.

16 May 2017

BRIEF-Astrazeneca Pharma India posts March-qtr loss

* March quarter total income from operations 1.12 billion rupees

09 May 2017

Earnings vs. Estimates

No consensus analysis data available.